Pharmagen, Inc. announced consolidated earnings results for the third quarter and nine months ended September 30, 2013. For the third quarter, the company reported total revenues were $1.074 million compared to $1.781 million for the quarter ended September 30, 2012.

For the nine months, the company reported total revenues were $3.770 million compared to $3.246 million for the nine months ended September 30, 2012. While this is modest year to date growth, gross profit year to date more than doubled from $1.071 million for the nine months ended September 30, 2012 to $2.404 million for the nine months ended September 30, 2013.